190 related articles for article (PubMed ID: 37864213)
1. Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.
Ma R; Guan X; Teng N; Du Y; Ou S; Li X
BMC Med Genomics; 2023 Oct; 16(1):254. PubMed ID: 37864213
[TBL] [Abstract][Full Text] [Related]
2. An assessment of the relationship between the expression of CCR7/CCL19 axis and selected regulatory miRNAs in non-small cell lung cancer.
Baran K; Kiszałkiewicz J; Migdalska-Sęk M; Jabłoński S; Kordiak J; Antczak A; Góralska K; Brzeziańska-Lasota E
Mol Biol Rep; 2019 Oct; 46(5):5389-5396. PubMed ID: 31463641
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
4. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.
Xu B; Zhou M; Qiu W; Ye J; Feng Q
Cancer Med; 2017 May; 6(5):1062-1071. PubMed ID: 28378417
[TBL] [Abstract][Full Text] [Related]
5. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
7. Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking.
Gao X; Zhang W; Jia Y; Xu H; Zhu Y; Pei X
Sci Rep; 2022 Sep; 12(1):16247. PubMed ID: 36171401
[TBL] [Abstract][Full Text] [Related]
8. ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort.
Fernandes M; Marques H; Teixeira AL; Medeiros R
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008626
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel lncRNA-miRNA-mRNA competing endogenous RNA network associated with prognosis of breast cancer.
Wan X; Hao S; Hu C; Qu R
J Biochem Mol Toxicol; 2022 Aug; 36(8):e23089. PubMed ID: 35532246
[TBL] [Abstract][Full Text] [Related]
10. CCL19 has potential to be a potential prognostic biomarker and a modulator of tumor immune microenvironment (TIME) of breast cancer: a comprehensive analysis based on TCGA database.
Wang J; Qin D; Ye L; Wan L; Wang F; Yang Y; Ma Y; Yang H; Yang Z; Chen M; Jiang W; Zhang Q
Aging (Albany NY); 2022 May; 14(9):4158-4175. PubMed ID: 35550569
[TBL] [Abstract][Full Text] [Related]
11. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z
J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320
[TBL] [Abstract][Full Text] [Related]
12. Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database.
Song Y; Chu P; Li P; Li F
Comput Math Methods Med; 2022; 2022():1418232. PubMed ID: 35832124
[TBL] [Abstract][Full Text] [Related]
13. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
Tan Y; Lu L; Liang X; Chen Y
World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
[TBL] [Abstract][Full Text] [Related]
15. High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients.
Itakura M; Terashima Y; Shingyoji M; Yokoi S; Ohira M; Kageyama H; Matui Y; Yoshida Y; Ashinuma H; Moriya Y; Tamura H; Harigaya K; Matushima K; Iizasa T; Nakagawara A; Kimura H
Br J Cancer; 2013 Sep; 109(5):1100-8. PubMed ID: 23922113
[TBL] [Abstract][Full Text] [Related]
16. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.
Oliveira-Neto HH; de Souza PP; da Silva MR; Mendonça EF; Silva TA; Batista AC
Tumour Biol; 2013 Feb; 34(1):65-70. PubMed ID: 22976543
[TBL] [Abstract][Full Text] [Related]
17. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
Wang T; Zhang XD; Hua KQ
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
[TBL] [Abstract][Full Text] [Related]
18. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
[TBL] [Abstract][Full Text] [Related]
19. The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.
Peng C; Zhou K; An S; Yang J
Tumour Biol; 2015 Jan; 36(1):329-35. PubMed ID: 25256673
[TBL] [Abstract][Full Text] [Related]
20. A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.
Cao W; Zhou W; Li M; Zhang Z; Zhang X; Yang K; Yang S; Cao G; Chen B; Xiong M
Front Immunol; 2022; 13():951135. PubMed ID: 36483555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]